Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis
2016 ◽
Vol 59
(6)
◽
pp. 2612-2632
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):